People: Solazyme Inc (SZYM.O)

SZYM.O on Nasdaq

3.15USD
22 May 2015
Change (% chg)

-- (--)
Prev Close
$3.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
964,397
52-wk High
$12.44
52-wk Low
$2.00

Search Stocks

Licari, Peter 

Dr. Peter J. Licari, Ph.D., is Chief Technology Officer of Solazyme Inc. From 2010 to 2012, he served as Executive Vice President, Research and Development. He served as our Senior Vice President, Research and Development from 2008 until 2010. From 1998 to 2008, Dr. Licari held various positions at Kosan Biosciences, Inc., a biopharmaceutical company. In his last position at Kosan Biosciences, Inc. he served as Senior Vice President, Manufacturing and Operations responsible for the process development and manufacturing of Kosan’s clinical compounds. From 1993 to 1996, Dr. Licari served as the Director of Vaccine Manufacturing and Development at Massachusetts Biologic Laboratories, a part of the University of Massachusetts, an academic institution. Prior to joining Massachusetts Biologic Laboratories, Dr. Licari held a variety of research positions at BASF Bioresearch Corporation, a biopharmaceutical company, and Merck & Co., Inc., a pharmaceutical company. Dr. Licari obtained his Ph.D. in Chemical Engineering from the California Institute of Technology and obtained an M.B.A. from Pepperdine University.

Basic Compensation

Total Annual Compensation, USD 412,515
Restricted Stock Awards, USD 306,750
Long-Term Incentive Plans, USD --
All Other, USD 767,822
Fiscal Year Total, USD 1,487,090

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 66,000 587,578.00
Name Fiscal Year Total

Jerry Fiddler

--

Jonathan Wolfson

2,960,850

Tyler Painter

4,315,470

Peter Licari

1,487,090

Paul Quinlan

1,286,740

Michael Arbige

--
As Of  30 Dec 2014
Search Stocks